[Benefits of functional imaging in radiotherapy]

P Vera; S Thureau

doi:10.1016/j.canrad.2015.06.018

[Benefits of functional imaging in radiotherapy]

Cancer Radiother. 2015 Oct;19(6-7):538-42. doi: 10.1016/j.canrad.2015.06.018. Epub 2015 Sep 3.

[Article in French]

Authors

P Vera¹, S Thureau²

Affiliations

¹ Département de médecine nucléaire, centre de lutte contre le cancer Henri-Becquerel, 1, rue d'Amiens, 76000 Rouen, France; FR CNRS 3638, laboratoire QuantIF (EA4108-Litis), rue d'Amiens, 76000 Rouen, France. Electronic address: Pierre.Vera@chb.unicancer.fr.
² Département de médecine nucléaire, centre de lutte contre le cancer Henri-Becquerel, 1, rue d'Amiens, 76000 Rouen, France; Département de radiothérapie, centre de lutte contre le cancer Henri-Becquerel, rue d'Amiens, 76000 Rouen, France; FR CNRS 3638, laboratoire QuantIF (EA4108-Litis), rue d'Amiens, 76000 Rouen, France.

PMID: 26344445
DOI: 10.1016/j.canrad.2015.06.018

Abstract

Functional imaging with positron emission tomography (PET) is interesting to optimize radiotherapy planning, and probably to perform dose redistribution in many cancers. However, in 2015, fluorodeoxyglucose (FDG)-PET is validated only for therapy planning for lung cancer. The interest of dose painting, PET in non-lung cancers, the interest of other tracers (even PET hypoxia tracers), DW-MRI, and PET-MR for radiotherapy needs to be demonstrated in prospective multicentric phase III studies on large series of patients.

Keywords: Hypoxia; Hypoxie; PET; Radiotherapy; Radiothérapie; TEP.

Publication types

English Abstract

MeSH terms

Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / radiotherapy*
Molecular Imaging*
Positron-Emission Tomography*
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
Radiotherapy, Image-Guided / methods*